S&P 500 and Dow Set New Milestones: What Investors Should Know
The S&P 500 hits a record high while the Dow crosses 54,000. What does this mean for investors?
Hadrian's $8 Billion Valuation: A New Era for Defense Tech Investments
Hadrian's recent $8 billion valuation highlights a booming interest in defense tech amid military upgrades.
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
Tarsus Pharmaceuticals Expands Eye Care Portfolio with Alkeus Acquisition
Tarsus Pharmaceuticals solidifies its eye care leadership with the acquisition of Alkeus Pharmaceuticals, targeting a ma…
Martin Marietta Secures Regulatory Approval: A Game Changer for the Materials Sector
Martin Marietta's regulatory approval for the Lhoist North America deal could reshape the materials market and investor …
Disney's New Streaming Strategy: Analyzing the Impact of Free Ad-Supported Tier
Disney may redefine streaming with a free ad-supported tier, capitalizing on advertising demand and industry trends.
S&P 500 and Dow Reach New Heights: What It Means for Investors
The S&P 500 and Dow have reached all-time highs, signaling potential opportunities and risks for retail investors.
US Labour Market Shows Signs of Cooling: ADP Jobs Report Misses Expectations
The latest ADP jobs report reveals a slowdown in US job growth, raising recession concerns and impacting rate cut expect…
Bears Capitulate: A Bullish Turn for Nasdaq 100 and Canadian Markets
The Nasdaq 100's top-10 bullish reading signals a pivotal shift, paralleled by record highs in U.S. indices and a surge …
Univar Solutions Expands Its Reach Through H.M. Royal Acquisition
Univar Solutions' acquisition of H.M. Royal enhances its capabilities in the U.S. specialty chemicals market.
SpaceX's Earnings Debut: A Critical Moment for Investors Following IPO
Investors are eagerly awaiting SpaceX's first earnings report since its IPO, with predictions of potential stock gains o…
Pfizer's Q2 Performance: A Shift Towards Non-Covid Growth
Pfizer exceeds Q2 earnings expectations, signaling a shift to non-Covid revenue streams and raising guidance for the hea…